Steven L. Stice
Gründer bei Aruna Bio, Inc.
Aktive Positionen von Steven L. Stice
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
Aruna Bio, Inc.
 Aruna Bio, Inc. Medical/Nursing ServicesHealth Services Aruna Bio, Inc. manufactures and provides neural stem cells. Its products include neuronet pure human neurons screening kit, neuronet pure human neurons discovery kit, co-culture kit hastropro-neuronet, hastropro human astrocytes kit and motor neurons GFP+htscreening kit. The company was founded by James Stice and Steven L. Stice in 2003 and is headquartered in Athens, GA. | Direktor/Vorstandsmitglied | - | - |
| Technik-/Wissenschafts-/F&E-Leiter | 01.01.2003 | - | |
| Gründer | 13.01.2010 | - | |
| Vorsitzender | 01.01.2003 | - |
Karriereverlauf von Steven L. Stice
Ehemalige bekannte Positionen von Steven L. Stice
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| University of Georgia | Corporate Officer/Principal | - | 04.07.2011 |
| OCATA THERAPEUTICS INC | Vorstandsvorsitzender | - | - |
| Technik-/Wissenschafts-/F&E-Leiter | - | - | |
| BresaGen, Inc. | Corporate Officer/Principal | - | - |
Statistik
International
| Vereinigte Staaten | 5 |
Operativ
| Chief Tech/Sci/R&D Officer | 2 |
| Corporate Officer/Principal | 2 |
| Director/Board Member | 1 |
Sektoral
| Health Services | 2 |
| Commercial Services | 2 |
| Consumer Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Private Unternehmen | 3 |
|---|---|
Aruna Bio, Inc.
Aruna Bio, Inc. Medical/Nursing ServicesHealth Services Aruna Bio, Inc. manufactures and provides neural stem cells. Its products include neuronet pure human neurons screening kit, neuronet pure human neurons discovery kit, co-culture kit hastropro-neuronet, hastropro human astrocytes kit and motor neurons GFP+htscreening kit. The company was founded by James Stice and Steven L. Stice in 2003 and is headquartered in Athens, GA. | Health Services |
| BresaGen, Inc. | Commercial Services |
Astellas Institute for Regenerative Medicine
 Astellas Institute for Regenerative Medicine Pharmaceuticals: MajorHealth Technology Astellas Institute for Regenerative Medicine engages in the development and commercialization of human pluripotent stem cell technology in the field of regenerative medicine. The company also have a preclinical development pipeline in areas outside of ophthalmology, including; autoimmune diseases, inflammatory diseases, and wound healing. The company was founded on May 18, 2000 and is headquartered in Marlborough, MA. | Health Technology |
- Börse
- Insiders
- Steven L. Stice
- Erfahrung
